Solventum Q3 Earnings Likely to Reflect Declining Volume Trend

Zacks11-06

Solventum SOLV is scheduled to release third-quarter 2024 results on Nov. 7, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 6.85%. SOLV ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481546607?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","is_english":true,"pubTime":"2024-11-06 20:52","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2481546607","market":"us","top_or_hot":-1,"title":"Solventum Q3 Earnings Likely to Reflect Declining Volume Trend","media":"Zacks","content":"<div>\n<p>Solventum SOLV is scheduled to release third-quarter 2024 results on Nov. 7, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 6.85%. SOLV ...</p>\n\n<a href=\"https://finance.yahoo.com/news/solventum-q3-earnings-likely-reflect-125200346.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Solventum Q3 Earnings Likely to Reflect Declining Volume Trend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSolventum Q3 Earnings Likely to Reflect Declining Volume Trend\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-06 20:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/solventum-q3-earnings-likely-reflect-125200346.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Solventum SOLV is scheduled to release third-quarter 2024 results on Nov. 7, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 6.85%. SOLV ...</p>\n\n<a href=\"https://finance.yahoo.com/news/solventum-q3-earnings-likely-reflect-125200346.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SOLV","symbol_name":"Solventum","start_time":0,"source_url":"https://finance.yahoo.com/news/solventum-q3-earnings-likely-reflect-125200346.html","article_id":"2481546607","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481546607","pubTimestamp":1730897520,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Solventum SOLV is scheduled to release third-quarter 2024 results on Nov. 7, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 6.85%. SOLV delivered a trailing four-quarter average earnings surprise of 15.7%.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Currently, the consensus estimate for revenues is pegged at $2.05 billion. The consensus mark for earnings is pinned at $1.38 per share.SOLV was spun off from diversified technology firm 3M Company. It started trading publicly on April 1, 2024. The company continues with separation activities, which include capital expenditure planning to drive top-line growth organically as well as through acquisitions. These actions are likely to put pressure on operating margin over the short-term and might have hurt earnings in the third quarter. Inflationary pressure and rising interest payments are likely to have hurt earnings as well.The stock has risen 69.4% y","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"SOLV":"Solventum","HAE":"美国血液技术"},"translate_title":"Solventum第三季度收益可能反映销量下降趋势","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SOLV":1,"HAE":0.9},"content_text":"Solventum SOLV is scheduled to release third-quarter 2024 results on Nov. 7, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 6.85%. SOLV delivered a trailing four-quarter average earnings surprise of 15.7%.\nStay up-to-date with all quarterly releases: See Zacks Earnings Calendar.\nSOLV Q3 Estimates\nCurrently, the consensus estimate for revenues is pegged at $2.05 billion. The consensus mark for earnings is pinned at $1.38 per share.\nFactors to Note\nSOLV was spun off from diversified technology firm 3M Company. It started trading publicly on April 1, 2024. The company continues with separation activities, which include capital expenditure planning to drive top-line growth organically as well as through acquisitions. These actions are likely to put pressure on operating margin over the short-term and might have hurt earnings in the third quarter. Inflationary pressure and rising interest payments are likely to have hurt earnings as well.\nAlthough Solventum registered higher volume during the second quarter, the company’s sales volume declined without the backorder benefit. The company has been facing declining volume for the past few quarters. Its revenue growth has been below par in several markets, with flat and declining volumes over the past two years. The declining volume trend is likely to have kept top-line growth under pressure in the third quarter as well. Meanwhile, foreign currency fluctuation might have been a headwind for the company.\nHowever, Solventum’s top line is expected to have benefited from improving pricing for its products. The company’s volume might have improved sequentially as it continues to serve its backorders. On its second-quarter earnings call, the company raised its full-year revenues growth expectation to 1% compared with the earlier guidance of flat to 2% decline in sales.\n\nSolventum Corporation Price and EPS Surprise\n\nSolventum Corporation price-eps-surprise | Solventum Corporation Quote\n\nEarnings Beat Likely\nOur proven model predicts an earnings beat for Solventum this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat.\nEarnings ESP: The company has an Earnings ESP of +1.46% at present. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.\nZacks Rank: The company currently carries a Zacks Rank #3.\nOther Stocks Worth a Look\nHere are a few other medical stocks worth considering, as these too have the right combination of elements to come up with an earnings beat this reporting cycle.\nBrainsway BWAY has an Earnings ESP of +100.00% and a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.\nThe stock has risen 69.4% year to date. BWAY’s earnings beat estimates in the last reported quarter. It has a trailing four-quarter average earnings surprise of 139.68%.\nHaemonetics HAE has an Earnings ESP of +0.18% and a Zacks Rank of 2 at present.\nThe stock fell 12.3% year to date. HAE’s earnings beat estimates in the last reported quarter. It has a trailing four-quarter average earnings surprise of 3.46%.\nICU Medical ICUI has an Earnings ESP of +2.67% and a Zacks Rank of 3 at present.\nThe stock has risen 73.8% year to date. ICUI’s earnings beat estimates in the last reported quarter. It has a trailing four-quarter average earnings surprise of 32.06%.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nHaemonetics Corporation (HAE) : Free Stock Analysis Report\nICU Medical, Inc. (ICUI) : Free Stock Analysis Report\nBrainsway Ltd. Sponsored ADR (BWAY) : Free Stock Analysis Report\nSolventum Corporation (SOLV) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481546607"}